In Vitro Activity of BAY y 3118, and Nine Other Antimicrobial Agents against Anaerobic Bacteria

REFERENCES

• Pankuch GA, Jacobs MR, Appelbaum PC. Susceptibility of 428 Gram-positive and -negative anaerobic bacteria to BAY y 3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillintazobactam, and cefoxitin. Antimicrob Agents Chemother 1993; 37: 1649-54.
   Google Scholar
• Summanen P, Baron EJ, Citron DM, Strong CA, Wexler HM, Finegold SM, eds. Wadsworth Anaerobic Bacteriology Manual. Belmont: Star Publishing Co., 1993.
   Google Scholar
• Aldridge KE. Increased activity of a new chlorofluoro-quinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agnts against anaerobic bacteria. Antimicrob Agents Chemother 1994; 38: 1671-74.
   Google Scholar
• Borgaerst GPA, Hoogkamp-Korstanje JAA. In vitro activities of BAY y 3118, ciprofloxacin, ofloxacin, and flerox-acin against Gram-negative pathogens from respiratory tract and soft tissue infections. Antimicrob Agents Chemother 1993; 37: 2017-19.
   Google Scholar
• Fass RJ. In vitro activity of BAY y 3118, a new quinolone. Antimicrob Agents Chemother 1993; 37: 2348-57.
   Google Scholar
• Garcia-Rodriguez JA, Garcia-Sanchez JE. Evolution of antimicrobial susceptibility in isolates of the Bacteroides frag-ilis group in Spain. Rev Infect Dis 1990; 12 (Suppl 2): S142–S51.
   Google Scholar
• Wexler HM, Molitoris E, Finegold SM. In vitro activity of BAY y 3118 against anaerobic bacteria. Antimicrob Agents Chemother 1993; 37: 2509-13.
   Google Scholar
• Appelbaum PC, Spangler SK, Jacobs MR. B-Lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulan a te, ticarcillin, ticar cillin - clavulan ate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother 1990; 34: 1546-50.
   Google Scholar
• Jacobs MR, Spangler SK, Appelbaum PC. B-Lactamase production, B-lactam sensitivity and resistance to synergy with davulanate of 737 Bacteroides fraggis group organisms from thirty-three US centres. J Antimicrob Chemother 1990; 26: 361–70.
   PubMed Web of Science ®Google Scholar
• Goldstein EJ, Citron DM. Comparative in vitro activity of the quinolones against anaerobic bacteria isolated at comu-nity hospitals. Antimicrob Agents Chemother 1985; 27: 657–9.
   PubMed Web of Science ®Google Scholar
• Goldstein EJ, Citron DM. Comparative in vitro activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57723 against anaerobic bacteria. Antimicrob Agents Chemother 1992. 36: 1158-62.
   Google Scholar
• Eliopoulos GM, Eliopoulos CT. Activity in vitro of the quinolones. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agnets. Washington, DC: American Society for Microbiology, 1993: 161–93.
   Google Scholar
• Venezia RA, Yocum DM, Robbiano EM, Echols RM. Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria. Antimicrob Agents Chemother 1990; 24: 1858-61.
   Google Scholar
• Wexler HM, Molitoris E, Finegold SM. In vitro activities of three of the newer quinolones against anaerobic bacte-ria. Antimicrob Agents Chemother 1992; 36: 239–43.
   PubMed Web of Science ®Google Scholar
• Domagala JM. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994; 33: 685–706.
   PubMed Web of Science ®Google Scholar
• Petersen U, Bremm K-D, Krebs A, Metzger KG, Philipps T, Schenke T. BAY y 3118, a novel 4-quinolone: synthesis and in vitro activity. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992: [Abstract n. 642].
   Google Scholar
• Bauerfeind A. Comparative in vitro activities of the new quinolone, BAY y 3118, and ciprofloxacin, sparfloxacin, tosu-floxacin, CI-960 and CI-990. J Antimicrob Chemother 1993; 31: 505–22.
   PubMed Web of Science ®Google Scholar
• Borobio MV, Conejo MAC, Ramirez E, Suarez, Al, Perea EJ. Comparative activities of eight quinolones against members of the Bacteroides fragilis group. Antimicrob Agents Chemother 1994; 38: 1442–5.
   PubMed Web of Science ®Google Scholar
• Bremm KD, Endermann R, Metzger KG. BAY y 3118, a new 4-quinolone: in vitro and in vivo activity against resistant staphylococci. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992: [Abstract n. 648].
   Google Scholar
• Bremm KD, Endermann R, Metzger KG. BAY y 3118, a new 4-quinolone: in vivo activity against Gram-positive cocci. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992: [Abstract n. 649].
   Google Scholar
• Brunner H. BAY y 3118, a novel 4-quinolone: efficacy in Myouplasma pneumoniae-infection of humans. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992: [Abstract n. 646].
   Google Scholar
• Endermann R, Bremm KD. BAY y 3118, a novel 4-quinolone: activity against anaerobes. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992: [Abstract n. 645].
   Google Scholar
• Garcia-Rodriguez JA, Garcia-Sanchez JE, Trujillano-Martin I, Garcia-Sanchez E, Garcia-Garcia MI, Fresnadillo M9J. Activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis. J Chemother 1994; 6: 102–6.
   Google Scholar
• Krasemann C. BAY y 3118, a novel 4-quinolone: in vitro activity against quinolone sensitive and resistant pathogens, comparison between agardilution and agardiffu-sion test. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992: [Abstract n. 644].
   Google Scholar
• Piddock LJ, Marshall AJ, Jin Y-F. Activity of BAY y 3118 against quinolone-susceptible and -resistant Gram-negative and Gram-positive bacteria. Antimicrob Agents Chemother 1994; 38: 422–7.
   PubMed Web of Science ®Google Scholar
• Thurberg BE, Painter BG, Herrington JA, Federici JA, Remy JM, Barbiero ML. In vitro activity of BAY y 3118, a new quinolone. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992: [ Abstract n. 643].
   Google Scholar
• Wise R, Andrews JM, Brenwald N. The in vitro activity of BAY y 3118, a new chlorofluoroquinolone. J Antimicrob Chemother 1993; 31: 73–80.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria, Approved standards M11-A2 NCCLS, Villanova, Pa. 1991.
   Google Scholar